BCL2 and B-cell non-Hodgkin lymphoma: The presence of t(14;18) chromosomal translocation, a key genetic event in several B-cell lymphomas, suggests that the resulting overexpression of BCL2 can be potentially used as a unique biomarker to distinguish and enrich malignant cells.